Literature DB >> 25231903

Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain.

Kazuhiko Tagawa1, Hidenori Homma1, Ayumu Saito2, Kyota Fujita1, Xigui Chen1, Seiya Imoto2, Tsutomu Oka1, Hikaru Ito1, Kazumi Motoki1, Chisato Yoshida1, Hiroyuki Hatsuta3, Shigeo Murayama3, Takeshi Iwatsubo4, Satoru Miyano2, Hitoshi Okazawa5.   

Abstract

Using a high-end mass spectrometry, we screened phosphoproteins and phosphopeptides in four types of Alzheimer's disease (AD) mouse models and human AD postmortem brains. We identified commonly changed phosphoproteins in multiple models and also determined phosphoproteins related to initiation of amyloid beta (Aβ) deposition in the mouse brain. After confirming these proteins were also changed in and human AD brains, we put the proteins on experimentally verified protein-protein interaction databases. Surprisingly, most of the core phosphoproteins were directly connected, and they formed a functional network linked to synaptic spine formation. The change of the core network started at a preclinical stage even before histological Aβ deposition. Systems biology analyses suggested that phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS) by overactivated kinases including protein kinases C and calmodulin-dependent kinases initiates synapse pathology. Two-photon microscopic observation revealed recovery of abnormal spine formation in the AD model mice by targeting a core protein MARCKS or by inhibiting candidate kinases, supporting our hypothesis formulated based on phosphoproteome analysis.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231903     DOI: 10.1093/hmg/ddu475

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

Review 1.  Protein kinase C mechanisms that contribute to cardiac remodelling.

Authors:  Alexandra C Newton; Corina E Antal; Susan F Steinberg
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

Review 2.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

3.  Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ1-42 Oligomers Induced Neurotoxicity.

Authors:  Yudong Liu; Peng Zhang; Yabing Zheng; Chunlin Yang; Tong Du; Mengru Ge; Xiaotian Chang; Ruisheng Duan; Guozhao Ma
Journal:  Neurochem Res       Date:  2018-08-28       Impact factor: 3.996

4.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 5.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

6.  Impact of schizophrenia GWAS loci converge onto distinct pathways in cortical interneurons vs glutamatergic neurons during development.

Authors:  Dongxin Liu; Amy Zinski; Akanksha Mishra; Haneul Noh; Gun-Hoo Park; Yiren Qin; Oshoname Olorife; James M Park; Chiderah P Abani; Joy S Park; Janice Fung; Farah Sawaqed; Joseph T Coyle; Eli Stahl; Jaroslav Bendl; John F Fullard; Panos Roussos; Xiaolei Zhang; Patric K Stanton; Changhong Yin; Weihua Huang; Hae-Young Kim; Hyejung Won; Jun-Hyeong Cho; Sangmi Chung
Journal:  Mol Psychiatry       Date:  2022-06-14       Impact factor: 13.437

7.  Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Karina Ausín; Paz Cartas-Cejudo; Mercedes Lachén-Montes; José Antonio Del Rio; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

8.  Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease.

Authors:  Stephanie I Alfonso; Julia A Callender; Basavaraj Hooli; Corina E Antal; Kristina Mullin; Mathew A Sherman; Sylvain E Lesné; Michael Leitges; Alexandra C Newton; Rudolph E Tanzi; Roberto Malinow
Journal:  Sci Signal       Date:  2016-05-10       Impact factor: 8.192

9.  Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease.

Authors:  Sedra Alabed; Heping Zhou; Ilker K Sariyer; Sulie L Chang
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

10.  Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart Review.

Authors:  Alon Seifan; Stephanie Assuras; Edward D Huey; Jesse Mez; Angeliki Tsapanou; Elise Caccappolo
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.